S/1999/285
16 March 1999
LETTER
DATED 16 MARCH 1999 FROM THE CHARGE D'AFFAIRES A.I. OF THE UNITED STATES
MISSION TO THE UNITED NATIONS ADDRESSED TO THE PRESIDENT OF THE SECURITY
COUNCIL
I have
the honour to enclose a copy of the letter from the Executive Chairman
of the United Nations Special Commission, Richard Butler, to the President
of the Security Council, dated 11 March 1999.
I should
be grateful if you would have the text of the present letter and of its
annex circulated as a document of the Security Council.
(Signed)
A. Peter BURLEIGH
Charge d'affaires a.i.
Annex
Letter
dated 11 March 1999 from the Executive Chairman of the Special Commission
established by the Secretary-General pursuant to paragraph 9 (b) (i) of
Security Council resolution 687 (1991) addressed to the President of the
Security Council
By letter
of 28 February 1999, the Permanent Representative of Iraq transmitted
to the Secretary-General a letter from the Minister for Foreign Affairs
of Iraq. These communications were circulated as a document of the Security
Council (S/1999/219).
In both
the above letters, reference is made to the spread of foot and mouth disease
among Iraqi livestock, and it is said that this results from a shortage
of vaccine, "particularly since work in the laboratory that was producing
the vaccine was halted when the United Nations Special Commission (UNSCOM)
destroyed all its equipment." This does not accord with the facts.
I believe
it is important to provide you, and through you the members of the Security
Council, with the pertinent facts in this case. These are given in the
annex to this letter. I have already provided the same information on
this issue to the Secretary-General.
I would
be grateful if this letter and its annex could be circulated as a document
of the Security Council.
(Signed)
Richard BUTLER
Enclosure
Production of foot and mouth disease vaccine in Iraq
In 1982,
a facility was installed by a foreign company at Daura, in Iraq, intended
to produce 12 million doses per year of foot and mouth disease vaccine.
According to Iraq, the best production level ever achieved was between
1 and 2 million doses per year. This plant was declared by Iraq to the
Special Commission in November 1991 as a civilian facility for the production
of vaccines. Following on the Commission's own inspections, analyses and
investigations, Iraq admitted, in July 1995, that Daura was not a purely
civilian facility, but had been used for biological warfare agent production,
research and development.
According
to the 1995 disclosure, the facility was taken over in 1990 by Iraq's
Technical Research Centre for the biological warfare programme. In Iraq's
own declarations, it is stated that large-scale production of the biological
warfare agent botulinum toxin took place at this facility, using some
of the equipment procured for foot and mouth disease vaccine production.
Research was also undertaken on viral agents for Iraq's biological warfare
programme, including camelpox, enterovirus 70 and rotavirus. Iraq further
declared that a genetic engineering research and development programme
was initiated for biological warfare purposes at the facility.
As a result
of modifications introduced by Iraq to the facility for the production
of biological weapons, foot and mouth disease vaccine was no longer produced.
Production of this vaccine was briefly resumed in 1992, following a reconfiguration
of the facility after the Gulf war, as part of Iraq's attempt to conceal
its biological warfare programme. After September 1992, Iraq discontinued
all production of vaccine, although staff and equipment remained at the
site. Thereafter, through the good offices of the Food and Agriculture
Organization of the United Nations (FAO), Iraq imported foot and mouth
disease vaccine, as it had done previously.
After
Iraq's eventual admission, in 1995, that it had had an extensive biological
warfare programme, the Commission, in accordance with Security Council
resolution 687 (1991), proceeded to supervise the destruction of installations,
facilities and equipment which had been used in that proscribed programme.
Accordingly, in 1996, 28 pieces of equipment at Daura, which had been
identified by Iraq as used for biological warfare production, were removed
from the facility and destroyed by Iraq under the Commission's supervision,
and special air-handling equipment at the facility was disabled. Some
40 major pieces, originally imported for the production of foot and mouth
disease vaccine, remained, as their use in the biological warfare programme
had not been established.
Taking
into account the above-mentioned facts, it is thus false to state that
the production of foot and mouth disease vaccine was halted when the Commission
destroyed all the equipment at Daura. Production of the vaccine was halted
unilaterally by Iraq in September 1992. Furthermore, not all the equipment
at the facility was destroyed by UNSCOM in 1996. Foot
and mouth disease vaccine is on the list of items subject to the Commission's
export/import monitoring system and thus its import should be reported
to the Commission. However, the Commission's mechanism in this respect
is purely one of notification and imposes no impediment on import.
11 March
1999
|